Myasthenia Gravis (MG) Market Analysis & Forecast to 2032: Global Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs, Key Players
24 janv. 2024 03h43 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...
Global Myasthenia Gravis Treatment Market Forecast and Trends 2023-2028, Featuring Profiles of AbbVie, Bausch Health, Gilead Sciences, Merck, Servier and Teva
18 déc. 2023 06h43 HE
|
Research and Markets
Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market: Forecast and Trends" report has been added to ResearchAndMarkets.com's offering. The global market for...
Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst, Cabaletta Bio, Janssen, Argenx, UCB Pharma, Alexion, Immunovant
25 oct. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Myasthenia Gravis Market is Projected to Boost at a Moderate Growth Rate by 2032, Estimates DelveInsight | Leading Companies - DAS-MG, Catalyst,...
Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research
15 mai 2023 21h00 HE
|
Allied Market Research
Portland, OR, May 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Myasthenia Gravis Treatment Market by Drug class (Monoclonal antibodies, Intravenous...
Outlook on the Myasthenia Gravis Diagnosis and Treatment Global Market to 2028 - Featuring Avadel Pharmaceuticals, Bausch Health Companies, Baxter International and CSL Behring Among Others
05 janv. 2023 06h58 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Diagnosis and Treatment Market Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global...
Myasthenia Gravis Market to Reach US$ 2.4 Bn by 2027, TMR Report
28 juil. 2022 13h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 28, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: Analysts at TMR estimate the myasthenia gravis market to clip a CAGR of 8% during the...
Global Myasthenia Gravis Market Will Reach USD 2,091 Million By 2025: Zion Market Research
19 mars 2019 09h07 HE
|
Zion Market Research
New York, NY, March 19, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Myasthenia Gravis Market by Diagnosis (Edrophonium Tests, Blood Tests, Pulmonary Function...
Myasthenia Gravis Market to become worth US$2,313.1 mn by 2025, Says TMR
18 juin 2018 05h53 HE
|
Transparency Market Research
Albany, NY, June 18, 2018 (GLOBE NEWSWIRE) -- According to a research report by Transparency Market Research (TMR), the global myasthenia gravis market is expected to expand at a steady CAGR of...